| Year |
Citation |
Score |
| 2024 |
Bhattarai KR, Mobley RJ, Barnett KR, Ferguson DC, Hansen BS, Diedrich JD, Bergeron BP, Yoshimura S, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, ... ... Savic D, et al. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nature Communications. 15: 3681. PMID 38693155 DOI: 10.1038/s41467-024-48124-4 |
0.355 |
|
| 2023 |
Bhattarai KR, Mobley RJ, Barnett KR, Ferguson DC, Hansen BS, Diedrich JD, Bergeron BP, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, ... ... Savic D, et al. Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Medrxiv : the Preprint Server For Health Sciences. PMID 36798219 DOI: 10.1101/2023.02.10.23285762 |
0.35 |
|
| 2020 |
Autry RJ, Paugh SW, Carter R, Shi L, Liu J, Ferguson DC, Lau CE, Bonten EJ, Yang W, McCorkle JR, Beard JA, Panetta JC, Diedrich JD, Crews KR, Pei D, ... ... Savic D, et al. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia. Nature Cancer. 1: 329-344. PMID 32885175 DOI: 10.1038/S43018-020-0037-3 |
0.342 |
|
| 2020 |
Lee SHR, Qian M, Yang W, Diedrich JD, Raetz E, Yang W, Dong Q, Devidas M, Pei D, Yeoh A, Cheng C, Pui CH, Evans WE, Mullighan CG, Hunger SP, ... Savic D, et al. Genome-wide association study of susceptibility loci for TCF3-PBX1 acute lymphoblastic leukemia in children. Journal of the National Cancer Institute. PMID 32882024 DOI: 10.1093/jnci/djaa133 |
0.32 |
|
| 2020 |
Partridge EC, Chhetri SB, Prokop JW, Ramaker RC, Jansen CS, Goh ST, Mackiewicz M, Newberry KM, Brandsmeier LA, Meadows SK, Messer CL, Hardigan AA, Coppola CJ, Dean EC, Jiang S, ... Savic D, et al. Occupancy maps of 208 chromatin-associated proteins in one human cell type. Nature. 583: 720-728. PMID 32728244 DOI: 10.1038/S41586-020-2023-4 |
0.446 |
|
| 2019 |
Pham D, Moseley CE, Gao M, Savic D, Winstead CJ, Sun M, Kee BL, Myers RM, Weaver CT, Hatton RD. Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf. Cell Reports. 29: 1203-1220.e7. PMID 31665634 DOI: 10.1016/J.Celrep.2019.09.064 |
0.371 |
|
| 2017 |
Ramaker RC, Savic D, Hardigan AA, Newberry K, Cooper GM, Myers RM, Cooper SJ. A genome-wide interactome of DNA-associated proteins in the human liver. Genome Research. PMID 29021291 DOI: 10.1101/Gr.222083.117 |
0.392 |
|
| 2017 |
Chisolm DA, Savic D, Moore AJ, Ballesteros-Tato A, León B, Crossman DK, Murre C, Myers RM, Weinmann AS. CCCTC-Binding Factor Translates Interleukin 2- and α-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs. Immunity. 47: 251-267.e7. PMID 28813658 DOI: 10.1016/J.Immuni.2017.07.015 |
0.368 |
|
| 2016 |
Savic D, Ramaker RC, Roberts BS, Dean EC, Burwell TC, Meadows SK, Cooper SJ, Garabedian MJ, Gertz J, Myers RM. Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Medicine. 8: 74. PMID 27401066 DOI: 10.1186/S13073-016-0328-6 |
0.329 |
|
| 2016 |
Engel KL, Mackiewicz M, Hardigan AA, Myers RM, Savic D. Decoding transcriptional enhancers: Evolving from annotation to functional interpretation. Seminars in Cell & Developmental Biology. PMID 27224938 DOI: 10.1016/J.Semcdb.2016.05.014 |
0.442 |
|
| 2015 |
Savic D, Roberts BS, Carleton JB, Partridge EC, White MA, Cohen BA, Cooper GM, Gertz J, Myers RM. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/enhancer-binding protein beta binding sites. Genome Research. PMID 26486725 DOI: 10.1101/Gr.191593.115 |
0.407 |
|
| 2015 |
Savic D, Partridge EC, Newberry KM, Smith SB, Meadows SK, Roberts BS, Mackiewicz M, Mendenhall EM, Myers RM. CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins. Genome Research. 25: 1581-9. PMID 26355004 DOI: 10.1101/Gr.193540.115 |
0.335 |
|
| 2015 |
Bailey KA, Savic D, Zielinski M, Park SY, Wang LJ, Witkowski P, Brady M, Hara M, Bell GI, Nobrega MA. Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice. Human Molecular Genetics. 24: 1646-54. PMID 25398947 DOI: 10.1093/Hmg/Ddu577 |
0.587 |
|
| 2013 |
Savic D, Gertz J, Jain P, Cooper GM, Myers RM. Mapping genome-wide transcription factor binding sites in frozen tissues. Epigenetics & Chromatin. 6: 30. PMID 24279905 DOI: 10.1186/1756-8935-6-30 |
0.42 |
|
| 2013 |
Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM. Distinct properties of cell-type-specific and shared transcription factor binding sites. Molecular Cell. 52: 25-36. PMID 24076218 DOI: 10.1016/J.Molcel.2013.08.037 |
0.375 |
|
| 2013 |
Savic D, Park SY, Bailey KA, Bell GI, Nobrega MA. In vitro scan for enhancers at the TCF7L2 locus. Diabetologia. 56: 121-5. PMID 23011354 DOI: 10.1007/S00125-012-2730-Y |
0.63 |
|
| 2012 |
Savic D, Bell GI, Nobrega MA. An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers. Plos One. 7: e36501. PMID 22590553 DOI: 10.1371/Journal.Pone.0036501 |
0.637 |
|
| 2012 |
Sakabe NJ, Savic D, Nobrega MA. Transcriptional enhancers in development and disease. Genome Biology. 13: 238. PMID 22269347 DOI: 10.1186/Gb-2012-13-1-238 |
0.597 |
|
| 2011 |
Savic D, Distler MG, Sokoloff G, Shanahan NA, Dulawa SC, Palmer AA, Nobrega MA. Modulation ofTcf7l2 expression alters behavior in mice. Plos One. 6: e26897. PMID 22046400 DOI: 10.1371/Journal.Pone.0026897 |
0.594 |
|
| 2011 |
Savic D, Ye H, Aneas I, Park SY, Bell GI, Nobrega MA. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Research. 21: 1417-25. PMID 21673050 DOI: 10.1101/Gr.123745.111 |
0.656 |
|
| Show low-probability matches. |